BioMed Research International
Volume 2018 (2018), Article ID 6795629, 2 pages
https://doi.org/10.1155/2018/6795629

Corrigendum

Corrigendum to “Expression of HE4 in Endometrial Cancer and Its Clinical Significance”

Xiao Li, Yiping Gao, Mingzi Tan, Huiyu Zhuang, Jian Gao, Zhenhua Hu, Huimin Wang, Liancheng Zhu, Juanjuan Liu, and Bei Lin

Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China

Correspondence should be addressed to Bei Lin; linbei88@hotmail.com

Received 17 July 2018; Accepted 31 July 2018; Published 12 September 2018

Copyright © 2018 Xiao Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Expression of HE4 in Endometrial Cancer and Its Clinical Significance” [1], there were errors in Figures 2(b) and 2(c), where some points were outside the survival curve due to a software error. The corrected version of Figure 2 is shown below.

(a)

(b)

(c)

(d)

Figure 2: Comparison of survival rates. Curves of deaths stratified by (a) HE4 strong positive; (b) stage; (c) differentiation; and (d) lymphatic metastasis.

Supplementary Materials

The raw data used in each version of SPSS. (Supplementary Materials)

References

Xiao Li, Yiping Gao, Mingz Tan I et al., “Expression of HE4 in Endometrial Cancer and Its Clinical Significance,” BioMed Research International, vol. 2015, Article ID 437468, 8 pages, 2015.